The aim of this study was to evaluate the spectrum and distribution of KRAS mutations in a large collection of CRC tissues, while also evaluating the concordance of primary and metastatic lesions among the available paired specimens from the same patients. This evidence concerns the gene KRAS and colorectal carcinoma.